Literature DB >> 34853152

Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction.

Michael Ippolito1, Francesco De Pascali1, Asuka Inoue1, Jeffrey L Benovic2.   

Abstract

G protein-coupled receptors (GPCRs) transduce a diverse variety of extracellular stimuli into intracellular signaling. These receptors are the most clinically productive drug targets at present. Despite decades of research on the signaling consequences of molecule-receptor interactions, conformational components of receptor-effector interactions remain incompletely described. The β 2-adrenergic receptor (β 2AR) is a prototypical and extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich pharmacopeia. Using bioluminescence resonance energy transfer -based biosensors, second messenger assays, and biochemical techniques, we characterize the properties of β 2AR-F193A. This single point mutation in extracellular loop 2 of the β 2AR is sufficient to intrinsically bias the β 2AR away from β-arrestin interaction and demonstrates altered regulatory outcomes downstream of this functional selectivity. This study highlights the importance of extracellular control of intracellular response to stimuli and suggests a previously undescribed role for the extracellular loops of the receptor and the extracellular pocket formed by transmembrane domains 2, 3, and 7 in GPCR regulation that may contribute to biased signaling at GPCRs. SIGNIFICANCE STATEMENT: The role of extracellular G protein-coupled receptor (GPCR) domains in mediating intracellular interactions is poorly understood. We characterized the effects of extracellular loop mutations on agonist-promoted interactions of GPCRs with G protein and β-arrestin. Our studies reveal that F193 in extracellular loop 2 in the β2-adrenergic receptor mediates interactions with G protein and β-arrestin with a biased loss of β-arrestin binding. These results provide new insights on the role of the extracellular domain in differentially modulating intracellular interactions with GPCRs.
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34853152      PMCID: PMC8969133          DOI: 10.1124/molpharm.121.000332

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  44 in total

Review 1.  Targeting G protein-coupled receptor signaling in asthma.

Authors:  Deepak A Deshpande; Raymond B Penn
Journal:  Cell Signal       Date:  2006-07-07       Impact factor: 4.315

2.  Pathway and mechanism of drug binding to G-protein-coupled receptors.

Authors:  Ron O Dror; Albert C Pan; Daniel H Arlow; David W Borhani; Paul Maragakis; Yibing Shan; Huafeng Xu; David E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-21       Impact factor: 11.205

3.  G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β2-adrenergic receptor.

Authors:  Minjung Choi; Dean P Staus; Laura M Wingler; Seungkirl Ahn; Biswaranjan Pani; William D Capel; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

Review 4.  Biased Agonism in Drug Discovery-Is It Too Soon to Choose a Path?

Authors:  Martin C Michel; Steven J Charlton
Journal:  Mol Pharmacol       Date:  2018-01-11       Impact factor: 4.436

5.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.

Authors:  O B Goodman; J G Krupnick; F Santini; V V Gurevich; R B Penn; A W Gagnon; J H Keen; J L Benovic
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

Review 6.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

7.  Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR).

Authors:  Ryan T Strachan; Jin-peng Sun; David H Rominger; Jonathan D Violin; Seungkirl Ahn; Alex Rojas Bie Thomsen; Xiao Zhu; Andrew Kleist; Tommaso Costa; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

8.  Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells.

Authors:  Qingwen Wan; Najeah Okashah; Asuka Inoue; Rony Nehmé; Byron Carpenter; Christopher G Tate; Nevin A Lambert
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

9.  Diverse GPCRs exhibit conserved water networks for stabilization and activation.

Authors:  A J Venkatakrishnan; Anthony K Ma; Rasmus Fonseca; Naomi R Latorraca; Brendan Kelly; Robin M Betz; Chaitanya Asawa; Brian K Kobilka; Ron O Dror
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-06       Impact factor: 11.205

10.  Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation.

Authors:  Shivani Ahuja; Viktor Hornak; Elsa C Y Yan; Natalie Syrett; Joseph A Goncalves; Amiram Hirshfeld; Martine Ziliox; Thomas P Sakmar; Mordechai Sheves; Philip J Reeves; Steven O Smith; Markus Eilers
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

View more
  2 in total

Review 1.  Selective Signal Capture from Multidimensional GPCR Outputs with Biased Agonists: Progress Towards Novel Drug Development.

Authors:  Donghwa Kim; Alina Tokmakova; Jung-A A Woo; Steven S An; William A Goddard; Stephen B Liggett
Journal:  Mol Diagn Ther       Date:  2022-05-20       Impact factor: 4.476

Review 2.  Biased β-Agonists Favoring Gs over β-Arrestin for Individualized Treatment of Obstructive Lung Disease.

Authors:  Alina Tokmakova; Donghwa Kim; William A Goddard; Stephen B Liggett
Journal:  J Pers Med       Date:  2022-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.